Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome

Bittner, V.A. ✉; Szarek, M.; Aylward, P.E.; Bhatt, D.L.; Diaz, R.; Edelberg, J.M.; Fras, Z.; Goodman, S.G.; Halvorsen, S.; Hanotin, C.; Harrington, R.A.; Jukema, J.W.; Loizeau, V.; Moriarty, P.M.; Moryusef, A.; Pordy, R.; Roe, M.T.; Sinnaeve, P.; Tsimikas, S.; Vogel, R.; White, H.D.; Zahger, D.; Zeiher, A.M.; Steg, P.G.; Schwartz, G.G.; Kiss, Róbert Gábor [Kiss, Róbert Gábor (Kardiológia), Collaborator]; Merkely, Béla [Merkely, Béla Péter (Kardiológia), Collaborator] Cardiovascular Center (SU / FM / C); Department of Cardiology – Heart and Vascular C... (SU / FM / C); Faculty of Sports Medicine (SU / FM / C); Horvath, I [Horváth, Iván (Kardiológia), Collaborator] Medical School (UP); ODYSSEY OUTCOMES Committees and Investigators [Collaborative Organization]